Clinical Assessment of Thrombosis in Children After Heart Surgery
CATCH
1 other identifier
observational
400
1 country
1
Brief Summary
Thromboembolic complications (TCs) are important causes of morbidity and mortality after pediatric cardiac surgery, resulting in longer hospital stay, increased risk of early and late post-surgical complications, early reoperation, neurologic and organ damage, and potentially death. The true incidence of blood clots in pediatric surgical patients is unknown. The overarching objective of this study is to further our understanding of TCs, including quantification, characterization and risk stratification. This study will ultimately allow the development of effective tools for prevention and early identification of TCs, rather than focusing on treatment alone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2011
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2011
CompletedFirst Submitted
Initial submission to the registry
September 8, 2011
CompletedFirst Posted
Study publicly available on registry
September 16, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedFebruary 1, 2016
January 1, 2016
3.3 years
September 8, 2011
January 29, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of Thromboembolic Complications (TC) after pediatric cardiac surgery
Thrombosis will be recorded through review of post-operative clinical assessments, targeted laboratory testing for blood abnormalities and echocardiographic/ultrasound evaluation.
Outcome will be recorded throughout the duration of the participants hospital stay, an expected average of 10 days
Secondary Outcomes (7)
Assessment of the patients' coagulation, hemostatic and inflammatory system activity
Baseline
Genome-Wide Association Study (GWAS)
Baseline
Post-operative sign and symptoms of thrombosis
Up to 10 days after surgery
Post-thrombotic Syndrome (PTS) Evaluation
Up to 2 years after surgery
Neurodevelopment and functional health assessment
Up to 2 years post- surgery
- +2 more secondary outcomes
Study Arms (1)
Children undergoing heart surgery
The study will follow children undergoing cardiac surgery at The Hospital for Sick Children from pre-consultation, throughout surgery, recovery and post-operative follow-up
Interventions
Eligibility Criteria
Children Undergoing Pediatric Heart Surgery at the Hospital for Sick Children who agree to participate in the CATCH research study.
You may qualify if:
- Pediatric patients scheduled for cardiac surgery requiring cardiopulmonary Bypass
You may not qualify if:
- Known severe risk factors to thromboembolic complications
- Active cancer
- Congenital coagulopathy (e.g. haemophilia)
- No planned cardiology follow-up at the Hospital for Sick Children
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Hospital for Sick Children
Toronto, Ontario, M5G 1X8, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Brian W McCrindle, MD
The Hospital for Sick Children, Toronto Canada
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Staff Cardiologist
Study Record Dates
First Submitted
September 8, 2011
First Posted
September 16, 2011
Study Start
July 1, 2011
Primary Completion
November 1, 2014
Study Completion
December 1, 2015
Last Updated
February 1, 2016
Record last verified: 2016-01